210 related articles for article (PubMed ID: 11377802)
1. Mitochondrial contributions to cancer cell physiology: potential for drug development.
Preston TJ; Abadi A; Wilson L; Singh G
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):45-61. PubMed ID: 11377802
[TBL] [Abstract][Full Text] [Related]
2. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
Dickerson T; Jauregui CE; Teng Y
Future Med Chem; 2017 Dec; 9(18):2197-2210. PubMed ID: 29182013
[TBL] [Abstract][Full Text] [Related]
3. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.
Scatena R; Bottoni P; Botta G; Martorana GE; Giardina B
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C12-21. PubMed ID: 17475665
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-induced mitochondrial biogenesis in the rat hippocampus.
Gutsaeva DR; Suliman HB; Carraway MS; Demchenko IT; Piantadosi CA
Neuroscience; 2006; 137(2):493-504. PubMed ID: 16298077
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondria in fighting cancer.
Gogvadze V
Curr Pharm Des; 2011 Dec; 17(36):4034-46. PubMed ID: 22188453
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
8. Alteration of mitochondrial function and cell sensitization to death.
Gogvadze V; Zhivotovsky B
J Bioenerg Biomembr; 2007 Feb; 39(1):23-30. PubMed ID: 17549639
[TBL] [Abstract][Full Text] [Related]
9. Signalling apoptosis: a radical approach.
Carmody RJ; Cotter TG
Redox Rep; 2001; 6(2):77-90. PubMed ID: 11450987
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy.
Kohno K; Wang KY; Takahashi M; Kurita T; Yoshida Y; Hirakawa M; Harada Y; Kuma A; Izumi H; Matsumoto S
Int J Mol Sci; 2015 Aug; 16(8):19836-50. PubMed ID: 26307971
[TBL] [Abstract][Full Text] [Related]
11. Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling.
Hagland H; Nikolaisen J; Hodneland LI; Gjertsen BT; Bruserud Ø; Tronstad KJ
Expert Opin Ther Targets; 2007 Aug; 11(8):1055-69. PubMed ID: 17665978
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide protects renal mesangial cells against hyperglycemia‑mediated mitochondrial apoptosis by activating the ERK‑Yap signaling pathway and upregulating Sirt3 expression.
Li J; Li N; Yan S; Lu Y; Miao X; Gu Z; Shao Y
Mol Med Rep; 2019 Apr; 19(4):2849-2860. PubMed ID: 30816450
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between cell cycle induction and mitochondrial dysfunction during oxidative stress and nerve growth factor withdrawal in differentiated PC12 cells.
Bianco MR; Berbenni M; Amara F; Viggiani S; Fragni M; Galimberti V; Colombo D; Cirillo G; Papa M; Alberghina L; Colangelo AM
J Neurosci Res; 2011 Aug; 89(8):1302-15. PubMed ID: 21557293
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress and Reprogramming of Mitochondrial Function and Dynamics as Targets to Modulate Cancer Cell Behavior and Chemoresistance.
Falone S; Lisanti MP; Domenicotti C
Oxid Med Cell Longev; 2019; 2019():4647807. PubMed ID: 31915507
[No Abstract] [Full Text] [Related]
15. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
16. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.
Marchetti P; Zamzami N; Joseph B; Schraen-Maschke S; Méreau-Richard C; Costantini P; Métivier D; Susin SA; Kroemer G; Formstecher P
Cancer Res; 1999 Dec; 59(24):6257-66. PubMed ID: 10626821
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-Judges and Executioners of Cell Death Sentences.
Bhola PD; Letai A
Mol Cell; 2016 Mar; 61(5):695-704. PubMed ID: 26942674
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria: a hub of redox activities and cellular distress control.
Kakkar P; Singh BK
Mol Cell Biochem; 2007 Nov; 305(1-2):235-53. PubMed ID: 17562131
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria: a target for cancer therapy.
Armstrong JS
Br J Pharmacol; 2006 Feb; 147(3):239-48. PubMed ID: 16331284
[TBL] [Abstract][Full Text] [Related]
20. The role of mitochondria in cellular toxicity as a potential drug target.
Wu D; Wang X; Sun H
Cell Biol Toxicol; 2018 Apr; 34(2):87-91. PubMed ID: 29511917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
